SEC Form 4 research
| Issuer | ACADIA PHARMACEUTICALS INC |
|---|---|
| Tickers | ACAD |
| Reporting owners | 47 |
| Officers and directors | 25 |
| Last public filing | 2026-08-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-06 | Schneyer Mark C. | S | 9,292 | $29.34 | Not reported |
| 2026-08-07 | 2026-08-06 | Schneyer Mark C. | S | 5,000 | $29 | Not reported |
| 2026-08-07 | 2026-08-05 | Schneyer Mark C. | S | 5,849 | $29 | Not reported |
| 2026-07-31 | 2026-07-30 | Thompson Elizabeth H.Z. | S | 50 | $26.17 | Not reported |
| 2026-07-31 | 2026-07-30 | Thompson Elizabeth H.Z. | S | 16,508 | $26.13 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.